Basal Insulin Therapy in Type 2 Diabetes

2001480 citationsJournal Articlebronze Open Access

Authors

Julio Rosenstock · Dallas Diabetes Research Center

Sherwyn Schwartz · Diabetes & Glandular Disease Clinic

Charles M. Clark · Regenstrief Institute

Glen D. Park

David W. Donley · IQVIA (United States)

Mike B. Edwards · IQVIA (United States)

Abstract

In patients with type 2 diabetes, once-daily bedtime insulin glargine is as effective as once- or twice-daily NPH in improving and maintaining glycemic control. In addition, insulin glargine deonstrates a lower risk of nocturnal hypoglycemia and less weight gain compared with NPH insulin.

Topics & Keywords

Diabetes Management and Research Diabetes Treatment and Management Metabolism, Diabetes, and Cancer

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 24, Issue 4, pp. 631-636

DOI: 10.2337/diacare.24.4.631

Field-Weighted Citation Impact: 18.21